Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

7 Semiconductor Stocks Surging on the Back of the Tech Boom

By Josh Enomoto, InvestorPlace Contributor

Forming the backbone of the digitalization trend, investors should consider these surging semiconductor stocks.

3 Institutional Investor Favorites Ready to Rally Further

By Josh Enomoto, InvestorPlace Contributor

Betting alongside the top institutional investor favorites offer significant confidence and higher probabilities of success.

3 Energy Stocks That Warren Buffett Can’t Get Enough Of

By Josh Enomoto, InvestorPlace Contributor

Technology without power is fairly useless. With that in mind, below are intriguing Warren Buffett energy stocks to consider.

3 Robotics Stocks to Buy as Musk Teases Tesla Bot

By Josh Enomoto, InvestorPlace Contributor

With Tesla’s Elon Musk talking a big game about humanoid machines, interest could spike in compelling robotics stocks.

Citi Just Raised Its Price Target on Tesla (TSLA) Stock

By Josh Enomoto, InvestorPlace Contributor

Although Citi views Tesla as a near-term positive trade, longer-term catalyst questions in its eyes makes TSLA stock a “hold.”

3 Hypergrowth Stocks Poised for Millionaire-Making Gains

By Josh Enomoto, InvestorPlace Contributor

While hypergrowth stocks are dangerous for your portfolio, there are very few asset classes that offer the same upside potential.

What Is Going on With NexImmune (NEXI) Stock Today?

By Josh Enomoto, InvestorPlace Contributor

Embattled biotech firm NexImmune is attempting to make the best out of a terrible situation, thus boosting NEXI stock.

3 Healthcare Stocks to Buy Now to Profit From Aging Population Trends

By Josh Enomoto, InvestorPlace Contributor

With the baby boom turning into a retirement bonanza, investors should consider these senior-focused healthcare stocks.

7 Innovative Small-Cap Stocks With Huge Upside Potential

By Josh Enomoto, InvestorPlace Contributor

Although innovative small-cap stocks carry significant risks, they also offer tremendous upside potential that can’t be ignored.

7 Growth Stocks to Buy for Under $5 for Massive Gains

By Josh Enomoto, InvestorPlace Contributor

Although growth stocks under $5 are inherently risky and unpredictable, their very nature also facilitates robust upside potential.

Load More